The Friday Five – Breast Cancer Awareness Month
Follow and join the conversation with #BreastCancerAwarenessMonth
A wave of pink seems to wash over everything this time of year as companies, organizations, athletes, healthcare workers and individuals join the movement each October to show their support for National Breast Cancer Awareness Month. This week’s Friday Five highlights the latest in research, treatment, fund raising and prevention.
1st Talk Compliance Guest Talks Mammography Sharing and More
On this episode Catherine talks to Cristin Gardner, Director of Consumer Products & Markets at Life Image a healthcare network for exchanging clinical and operational information including medical images, about “Upholding HIPAA OCR Compliance & Streamlining Patient Access to Medical Data.” Digital innovation is transforming healthcare. The federal government has recently made significant pushes to make healthcare more consumer-friendly by creating easier access to health information and ePHI through technology. Find out how all of this applies to mammograms, breast cancer detection and women’s health.
1st Talk Compliance rebroadcasts at 7:30 am, 3:30 pm and 11:30 pm ET every weekday.
How Funding and Innovation is Paving the Way for Breast Cancer Research and Treatment
According to Douglas Feil, Chief Programs Officer at National Breast Cancer Foundation. breast cancer death rates have declined by more than 40% in the last 30 years thanks to improvements in early detection and treatment, but more than 40,000 women and men still die each year. That’s why the future of breast cancer must be rooted in drastically decreasing the mortality rate in the coming decades through scientific innovation, improved early detection methods, and more targeted therapy options for patients.
Our friends at the National Breast Cancer Foundation @NBCF are sharing how funding and innovation is paving the way for breast cancer research and treatment. Check it out: https://t.co/VOfUYt1mWb pic.twitter.com/zrodisWJNp
— Charity Navigator (@CharityNav) October 15, 2019
Following NCCN Guidelines for Metastatic Breast Cancer Results in Lower Costs for Patients, According to New Study
A new study from the O’Neal Comprehensive Cancer Center at University of Alabama at Birmingham (UAB), published in the October 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network, finds that direct costs for metastatic breast cancer (MBC) patients increase dramatically when their treatment differs from recommendations in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Previous studies have found that guideline discordant care results in higher health care costs overall[1], but this is the first study to look specifically at the cost burden for patients.
New research from @ONealCancerUAB shows that following #NCCNGuidelines for metastatic breast cancer results in lower costs for patients. https://t.co/eFnLFFtnxa @JNCCN #BCSM #BreastCancerAwarenessMonth #cancerresearch #mbc pic.twitter.com/as3kJyj9Os
— National Comprehensive Cancer Network (NCCN) (@NCCN) October 10, 2019
Breast Cancer Stamps
The next time you visit your local post office or go online to buy stamps choose to purchase a book of breast cancer stamps to help fund research.
#BreastCancerAwarenessMonth #BreastCancer #BreastCancerResearch #USPS @USPS @BreastCancerNow @BCCare https://t.co/7HvnGB7D0E
— Ty Kelley (@ty_kelley) October 17, 2019
Why the Women Most Likely to Die of Breast Cancer Have Gotten the Least Attention
Time Magazine reports that despite the billions of dollars collected and spent on breast-cancer research over the past half-century, relatively little has been devoted to studying metastatic-breast-cancer patients or their particular forms of the disease.
ICYMI – Our other Friday Fives and Blog posts from HCNR’s Nurse Lauren.
